The lipoatrophy syndromes are a heterogeneous group of syndromes characteri
zed by a paucity of adipose tissue. Severe lipoatrophy is associated with i
nsulin-resistant diabetes mellitus (DM). The loss of adipose tissue can hav
e a genetic, immune, or infectious/drug-associated etiology. Causative muta
tions have been identified in patients for one form of partial lipoatrophy
- Dunnigan-type familial partial lipodystrophy. Experiments using lipoatrop
hic mice demonstrate that the diabetes results from the lack of fat and tha
t leptin deficiency is a contributing factor Thiazolidinedione therapy impr
oves metabolic control in lipoatrophic patients; the efficacy of leptin tre
atment is currently being investigated.